Table 3.
p-value |
||
---|---|---|
DFS | OS | |
T category | .003 | .072 |
Node metastasis | < .001 | .011 |
Nuclear grade | .003 | .548 |
Histologic grade | .021 | .494 |
ER | .588 | .103 |
PR | .296 | .755 |
HER2 | .001 | .026 |
Ki-67 (≥ 20%) | .395 | - |
Type A/B | .127 | .877 |
Structure (MP) | .761 | .085 |
Structure (SRC) | .788 | .515 |
EIC | .772 | .914 |
LVI | < .001 | .127 |
DFS, disease-free survival; OS, overall survival; ER, estrogen receptor; PR, progesterone receptor; MP, micropapillary pattern; SRC, signet ring cell pattern; EIC, extensive intraductal component; LVI, lymphovascular invasion.